PointState Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-198,900
| Closed | -$26.3M | – | 165 |
|
2018
Q2 | $26.3M | Buy |
+198,900
| New | +$26.3M | 0.3% | 60 |
|
2018
Q1 | – | Sell |
-485,400
| Closed | -$27M | – | 178 |
|
2017
Q4 | $27M | Buy |
485,400
+84,400
| +21% | +$4.7M | 0.26% | 62 |
|
2017
Q3 | $18.2M | Sell |
401,000
-230,922
| -37% | -$10.5M | 0.15% | 81 |
|
2017
Q2 | $21.3M | Sell |
631,922
-6,978
| -1% | -$235K | 0.23% | 62 |
|
2017
Q1 | $18.9M | Buy |
+638,900
| New | +$18.9M | 0.2% | 71 |
|
2016
Q4 | – | Sell |
-270,000
| Closed | -$16.6M | – | 153 |
|
2016
Q3 | $16.6M | Buy |
270,000
+120,000
| +80% | +$7.37M | 0.17% | 77 |
|
2016
Q2 | $2.86M | Sell |
150,000
-750,000
| -83% | -$14.3M | 0.06% | 77 |
|
2016
Q1 | $17.6M | Buy |
900,000
+225,000
| +33% | +$4.39M | 0.47% | 31 |
|
2015
Q4 | $26M | Buy |
675,000
+275,000
| +69% | +$10.6M | 0.66% | 28 |
|
2015
Q3 | $12.8M | Sell |
400,000
-175,000
| -30% | -$5.62M | 0.36% | 40 |
|
2015
Q2 | $17.5M | Sell |
575,000
-175,000
| -23% | -$5.33M | 0.2% | 64 |
|
2015
Q1 | $9.96M | Buy |
750,000
+500,000
| +200% | +$6.64M | 0.13% | 78 |
|
2014
Q4 | $3.62M | Sell |
250,000
-475,000
| -66% | -$6.87M | 0.06% | 94 |
|
2014
Q3 | $15.3M | Sell |
725,000
-75,000
| -9% | -$1.58M | 0.28% | 52 |
|
2014
Q2 | $23.8M | Buy |
800,000
+200,000
| +33% | +$5.96M | 0.3% | 52 |
|
2014
Q1 | $14.4M | Buy |
+600,000
| New | +$14.4M | 0.23% | 65 |
|
2013
Q4 | – | Sell |
-485,000
| Closed | -$22.9M | – | 165 |
|
2013
Q3 | $22.9M | Buy |
+485,000
| New | +$22.9M | 0.39% | 52 |
|